GSK Consumer Healthcare to fight case against tech transfer

New Delhi: GSK Consumer Healthcare said it will contest an attempt by Steer Engineering to block the transfer of technology that quickens the process of making malt beverages to Hindustan Unilever as part of a planned merger.

“We are contesting allegations made by Steer Engineering and shall take all necessary legal steps before the Delhi High Court. As the matter is sub-judice, we are not in a position to share further details,” a GSK Consumer spokesperson said in response to ET’s query.

Unilever’s India unit announced on December 3 that it will merge GSK Consumer with itself in an all-stock deal that will give it access to Horlicks, Boost and Maltova malted drinks.

The merger values GSK Consumer at Rs 31,700 crore.

Following the merger announcement, Steer Engineering moved the Delhi High Court late last week seeking protection for the technology it had provided for the manufacture of malt beverages Horlicks and Boost.

Steer Engineering said the technology was given exclusively to GSK Consumer and it cannot be transferred to Hindustan Unilever since it is “against the original terms of the contract.”

The company said it has a confidentiality contract with GSK Consumer for the technology, which reduces the time taken to make Horlicks to 15 minutes from 18 hours.

  • Related Posts

    Civil society group SAM calls for greater transparency involving clinical trials

    The group had approached the Supreme Court, raising concerns on clinical trials in a Public Interest Litigation in 2012 Civil society group Swasthya Adhikar Manch (SAM) has called for greater…

    Different packaging, typos expose fake Mounjaro racket

    Gurugram: Colour dissimilarity to typographical errors… conspicuous differences in the packaging of counterfeit Mounjaro injections led the Drugs Control Office to crack down on the illicit sale and production of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Civil society group SAM calls for greater transparency involving clinical trials

    Civil society group SAM calls for greater transparency involving clinical trials

    Different packaging, typos expose fake Mounjaro racket

    Different packaging, typos expose fake Mounjaro racket

    To Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this Book

    To Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this Book

    NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

    NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

    Rajasthan Bans 7 Sub-Standard Medicines

    Rajasthan Bans 7 Sub-Standard Medicines

    ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

    ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection